Jakob Falur Gardarsson, general manager at Frumtök, the Icelandic Association of the Pharmaceutical Industry, highlights access as the main challenge that needs to be met in order to propel Iceland’s healthcare system to the level of other Northern European countries. He also expresses his trust in the willingness of the government to implement such change and position Iceland as a hub for research and development in Europe.
Mr. Gardarsson, could you please explain the key responsibilities of your association to our international readers?
"There are three main areas [of concern for our members]: transparency, pricing and access."
